Pathogenicity and immunogenicity in mice of vaccinia viruses mutated in the viral envelope proteins A33R and B5R

Antiviral Research

Volumn 69, Issue 3, 2006, Pages 158-164

  Gurt, Irina ^a   Abdalrhman, Ihab ^a   Katz, Ehud ^a  

^a HEBREW UNIVERSITY   (Israel)

Author keywords

Immunogenicity; Mutants; Pathogenicity; Vaccinia virus

Indexed keywords

UNCLASSIFIED DRUG; VIRUS ENVELOPE PROTEIN; VIRUS ENVELOPE PROTEIN A33R; VIRUS ENVELOPE PROTEIN B5R;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; FEMALE; IMMUNOGENICITY; INOCULATION; LETHAL DOSE; LUNG; MOUSE; NONHUMAN; ORGAN DISTRIBUTION; PRIORITY JOURNAL; VACCINIA VIRUS; VIRUS ATTENUATION; VIRUS ENVELOPE; VIRUS MUTATION; VIRUS STRAIN; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; BODY WEIGHT; BRAIN; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART; KIDNEY; LIVER; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PLAQUE ASSAY; VACCINIA; VACCINIA VIRUS; VIRAL ENVELOPE PROTEINS; VIRULENCE;

ANIMALIA; VACCINIA VIRUS;

EID: 32644454769     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2005.11.006     Document Type: Article

References (22)

1. G. Appleyard, A.J. Hapel, and E.A. Boulter An antigenic difference between intracellular and extracellular rabbitpox virus J. Gen. Virol. 13 1971 9 17
2. M. Carrol, and B. Moss Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line Virology 238 1997 198 211
3. P.L. Earl, J.L. Americo, and L.S. Wyatt Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox Nat. Med. 428 2004 182 185
4. M. Engelstad, S.T. Howard, and G.L. Smith A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope Virology 188 1992 801 810
5. F. Fenner, D.A. Henderson, I. Arita, Z. Jezek, and I.D. Ladnyi Smallpox and its eradication Geneva: World Health Organization 1988
6. C. Fogg, S. Lustig, J.C. Whitbeck, R.J. Eisenberg, G.H. Cohen, and B. Moss Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions J. Virol. 78 2004 10230 10237
7. S.N. Isaacs, E.J. Wolffe, L.G. Payne, and B. Moss Characterization of a vaccinia virus-encoded 42-kilodalton class I membrane glycoprotein component of the extracellular virus envelope J. Virol. 66 1992 7217 7224
8. E. Katz, B.M. Ward, A.S. Weisberg, and B. Moss Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein J. Virol. 77 2003 12266 12275
9. E. Katz, E.J. Wolffe, and B. Moss Identification of second site mutations that enhance release and spread of vaccinia virus J. Virol. 76 2002 11637 11644
10. M. Kidokoro, M. Tashiro, and H. Shida Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8 Proc. Natl. Acad. Sci. U.S.A. 102 2005 4152 4157
11. S. Lustig, C. Fogg, J.C. Whitbeck, R.J. Eisenberg, G.H. Cohen, and B. Moss Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge J. Virol. 79 2005 13454 13462
12. A. Mayr, H. Stickl, H.K. Muller, K. Danner, and H. Singer Der pockenimppfstamm MVA: marker, genetische struktur, erfahrungenmit der parenteralen schutzimpfung under verhalten im abwehrgeschwachten organismus Zbl Bakt Hyg 167 1978 375 390
13. J.B. Moore, and G.L. Smith Steroid hormone synthesis by a vaccinia enzyme - a new type of virus virulence factor EMBO J. 11 1992 1973 1980
14. B. Moss Poxviridae: the viruses and their replication 4th ed. D.M. Knipe P.M. Howley D.E. Griffin R.A. Lamb M.A. Martin B. Roizman S.E. Straus Fields Virology vol. 2 2001 Lippincott Williams and Wilkins Philadelphia, PA 2849 2883
15. J.M. Neff, R.H. Levine, J.M. Lane, E.A. Ager, H. Moore, B.J. Rosenstein, J.D. Millar, and D.A. Henderson Complications of smallpox vaccination United States II. Results obtained by four statewide surveys Pediatrics 39 1963 916 923
16. L. Payne Polypeptide composition of extracellular enveloped vaccinia virus J. Virol. 27 1978 28 37
17. R. Roper, L.G. Payne, and B. Moss Extracellular vaccinia virus envelope glycoprotein encoded by the A33R gene J. Virol. 70 1996 3753 3762
18. R. Roper, E.J. Wolffe, A. Weisberg, and B. Moss The envelope protein encoded by the A33R gene is required for formation of actin-containing microvilli and efficient cell-to-cell spread of vaccinia virus J. Virol. 72 1998 4192 4204
19. J.J. Sejvar, Y. Chowdary, and M. Schomogyi Monkeypox infection: a family cluster in the Midwestern United States J. Infect. Dis. 190 2004 1833 1840
20. G.S. Turner Respiratory infection of mice with vaccinia virus J. Gen. Virol. 1 1967 399 402
21. J.D. Williamson, R.W. Reith, L.J. Jeffrey, J.R. Arrand, and M. Macket Biological characterization of recombinant vaccinia viruses in mice infected by the respiratory route J. Gen. Virol. 71 1990 2761 2767
22. L.S. Wyatt, M.W. Carroll, C.P. Czerny, M. Merchlinsky, J.R. Sisler, and B. Moss Marker rescue of the host range restriction defects of modified vaccinia virus Ankara Virology 251 1998 334 342